By the early 2000s, many hospitals had hired yet another new type of middleman, called a group purchasing organization (GPO), to bargain with drugmakers on their behalf. Since GPO fees are based on a percentage of sales, they have little incentive to promote the use of the cheaper drugs because that decreases their revenues.
